| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.02 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.02 |